Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
---|
08/28/2001 | US6281366 Radiation transparent articles |
08/28/2001 | US6281356 Substituted pyrroles |
08/28/2001 | US6281243 Derivatives of azetidine and pyrrolidine |
08/28/2001 | US6281231 2,6-dichloro-4-pyridinemethanol derivatives and agricultural chemicals |
08/28/2001 | US6281227 Inhibitors of the activity of factor xa. |
08/28/2001 | US6281212 Chemokine receptor antagonists and methods of use therefor |
08/23/2001 | WO2001060811A1 Chromene compound |
08/23/2001 | WO2001060806A2 Substituted arylpyrazines |
08/23/2001 | WO2001060802A1 4-imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use as alpha-1a agonists |
08/23/2001 | WO2001007436A3 Substituted oxoazaheterocyclyl compounds |
08/23/2001 | US20010016657 Substituted isoquinoline derivatives and their use as anticonvulsants |
08/23/2001 | CA2651825A1 Substituted arylpyrazines |
08/23/2001 | CA2399147A1 4-imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use as alpha-1a agonists |
08/23/2001 | CA2398937A1 Substituted arylpyrazines |
08/22/2001 | EP1125931A1 Biocidal alkyl-substituted-(hetero)aryl-ketoxime-O-ethers and the production method thereof |
08/22/2001 | EP1124821A1 Compounds |
08/22/2001 | EP1124804A1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors |
08/22/2001 | EP0777653B1 Dihygropyridine derivatives as bradykinin antagonists |
08/22/2001 | EP0752854B1 Pyrimidine or triazine carboxylic acid derivatives to be used as medicaments |
08/22/2001 | CN1309656A Thioalkyl alpha-substd. pyrimidine compounds |
08/22/2001 | CN1309655A Cyclic compounds useful in treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions and preparation process |
08/22/2001 | CN1309634A Hydrazine derivs. |
08/21/2001 | US6277859 Highly selective kappa-opioid agonists useful as analgesics and diuretics with reduced physiological side effects |
08/21/2001 | US6277853 Indole derivatives as 5-HT1B and 5-HT1D agonists |
08/21/2001 | US6277839 Antiinflammatory agents, antipyretics, analgesics; side effect reduction |
08/21/2001 | US6277790 Substituted herbicide tetrazolinonecarboxylic acid amides |
08/21/2001 | US6277789 Substituted phenyluracils |
08/16/2001 | WO2001058893A2 Indol-3-yl derivatives and their use as integrin inhibitors |
08/16/2001 | WO2001058891A2 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage |
08/16/2001 | WO2001058890A1 Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2 |
08/16/2001 | WO2001058881A1 Pyrimidine derivatives as selective inhibitors of cox-2 |
08/16/2001 | WO2001058869A2 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
08/16/2001 | WO2001058853A1 Dehydroamino acids |
08/16/2001 | WO2001058852A2 (r)-2-aryl-propionamides, useful in the inhibition of il-8-induced chemiotaxis of neutrophils |
08/16/2001 | WO2001010842A3 Melanocortin-4 receptor binding compounds and methods of use thereof |
08/16/2001 | WO2001010381A3 Methods for treating or preventing pain and anxiety |
08/16/2001 | WO2001010380A3 Benzanilides as potassium channel openers |
08/16/2001 | WO2001009119A3 Chemokine receptor antagonists |
08/16/2001 | WO2001009115A3 A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3- (4-[2-(PIPERIDIN-1- YL)ETHOXY] PHENOXY)-2- (4-METHOXYPHENYL) BENZO[b]THIOPHENE HYDROCHLORIDE |
08/16/2001 | WO2001007435A3 N-(indolcarbonyl-)piperazin derivatives als 5-ht2a-receptor ligands |
08/16/2001 | WO2001007431A3 Benzothiophene derivatives |
08/16/2001 | WO2000047551A3 Inhibitors of aspartyl protease |
08/16/2001 | WO2000015212A3 Antifungal activity of dicationic molecules |
08/16/2001 | US20010014746 Preparation of substituted isoserine esters using metal alkoxides and beta-lactams |
08/16/2001 | US20010014745 Process for the prepartion of 6-(arylcarbonyl)-4-oximo-dihydrobenzothiopyran herbicides and intermediates useful therein |
08/16/2001 | US20010014688 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
08/16/2001 | US20010014683 Analgesics; side effect reduction |
08/16/2001 | US20010014681 Compounds useful for inhibition of farnesyl protein transferase |
08/16/2001 | US20010014677 Restenosis, kidney diseases, lung diseases |
08/16/2001 | EP1123931A1 Tricylic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
08/16/2001 | EP1123925A1 Process for preparation of substituted pyridines |
08/16/2001 | EP1123924A1 Substituted pyridines as HMG-COA reductase inhibitors |
08/16/2001 | EP1123918A1 Aromatic amine derivatives, process for the preparation thereof and agents containing the same |
08/16/2001 | EP1123291A1 Process for preparing 3-(substituted phenyl)-5-thienyl or furyl)-1,2,4-triazoles and novel intermediates utilized therein |
08/16/2001 | EP1123290A1 3-(substituted phenyl)-5-thienyl-1,2,4-triazole compounds with activity against whitefly |
08/16/2001 | EP1123287A1 Insecticidal 3- (substituted pyridyl) -1, 2, 4-triazoles |
08/16/2001 | EP1123285A1 Substituted benzopyran analogs for the treatment of inflammation |
08/16/2001 | EP0891345B1 Novel furan diarylmethylidene derivatives, method for their preparation and therapeutical uses thereof |
08/16/2001 | DE10006297A1 Substituierte Benzimidazole Substituted benzimidazoles |
08/16/2001 | DE10006139A1 Indol-3-yl-Derivate Indol-3-yl derivatives |
08/16/2001 | CA2399791A1 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
08/16/2001 | CA2398822A1 Piperazine and piperidine derivatives |
08/16/2001 | CA2397993A1 Dehydroamino acids |
08/15/2001 | CN1308627A 11-Aryl-benzo[b]naphtho[2,3-d]furans and 11-aryl-aryl-benzo[b]anphtho[2,3-d]thiophenes useful in the treatment of insulin resistance and hyperglycemia |
08/15/2001 | CN1308625A Naphtho [2,3-b] heteroar-4-yl derivatives |
08/15/2001 | CN1308622A Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
08/15/2001 | CN1308617A Antiviral macrocyclic compounds |
08/15/2001 | CN1308616A Non-peptidyl inhibitors and VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory disease |
08/15/2001 | CN1308606A Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use pharmaceutical preparations comprising them |
08/14/2001 | US6274613 Cyclic imines as pesticides |
08/14/2001 | US6274590 Administering 3,4-diarylthiophene derivative to treat eczema, burns, psoriasis, and dermatitis |
08/09/2001 | WO2001057037A1 Platelet adp receptor inhibitors |
08/09/2001 | WO2001057033A1 C10 carbamoyloxy substituted taxanes as antitumor agents |
08/09/2001 | WO2001057032A1 C10 ester substituted taxanes as antitumor agents |
08/09/2001 | WO2001057031A1 C10 carbonate substituted taxanes as antitumor agents |
08/09/2001 | WO2001057030A1 C7 carbonate substituted taxanes as antitumor agents |
08/09/2001 | WO2001057029A1 C7 heterosubstituted acetate taxanes as antitumor agents |
08/09/2001 | WO2001057028A1 C7 carbamoyloxy substituted taxanes as antitumor agents |
08/09/2001 | WO2001057027A1 C7 ester substituted taxanes as antitumor agents |
08/09/2001 | WO2001057025A1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes |
08/09/2001 | WO2001057024A1 Blockade of voltage dependent sodium channels |
08/09/2001 | WO2001057013A1 Taxane formulations having improved solubility |
08/09/2001 | WO2001056990A2 Pyridine derivates as potentiators of glutamate receptors |
08/09/2001 | WO2001056989A2 Inhibitors of factor xa |
08/09/2001 | WO2001056974A2 Inha inhibitors and their use as antibacterials |
08/09/2001 | WO2001056902A1 Inverted aerosol dispenser |
08/09/2001 | WO2001056607A1 Integrin expression inhibitors |
08/09/2001 | WO2001056570A1 Remedies or preventives for pulmonary insufficiency containing diaminotrifluoromethylpyridine derivatives |
08/09/2001 | WO2001056564A1 C10 heterosubstituted acetate taxanes as antitumor agents |
08/09/2001 | WO2001019814A3 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
08/09/2001 | WO2001019788A3 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa |
08/09/2001 | US20010012851 A carbamate, carbonate or carboxasulfide containing oxindole compound used for treating osteroarthritis, an inflammatory disease or degenerative joint disease without causing side effect |
08/09/2001 | CA2368541A1 C10 carbamoyloxy substituted taxanes as antitumor agents |
08/09/2001 | CA2368540A1 C7 carbonate substituted taxanes as antitumor agents |
08/09/2001 | CA2368534A1 C7 heterosubstituted acetate taxanes as antitumor agents |
08/09/2001 | CA2368510A1 C7 carbamoyloxy substituted taxanes as antitumor agents |
08/09/2001 | CA2368502A1 C10 heterosubstituted acetate taxanes as antitumor agents |
08/09/2001 | CA2368151A1 C10 carbonate substituted taxanes as antitumor agents |
08/09/2001 | CA2367661A1 Taxane formulations having improved solubility |
08/08/2001 | EP1121431A1 Non-endogenous, constitutively activated human g protein-coupled receptors |